10 hours ago
Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut
June 18 (Reuters) - Caris Life Sciences' (CAI.O), opens new tab shares jumped nearly 29% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025.
The shares opened at $27 apiece, compared with their offer price of $21, at which Caris Life sold 23.5 million shares to raise $494.1 million on Tuesday.
U.S. IPO market activity has shown signs of a sustained revival with a few fresh listings such as Circle and Chime (CHYM.O), opens new tab getting overwhelming support from investors in the past couple of weeks, after a slow start to the year.
Shares of insurance tech firm Slide (SLDE.O), opens new tab jumped nearly 24% in their Nasdaq debut on Wednesday as well.
